IRIS
MALERBA, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.833
NA - Nord America 2.376
AS - Asia 670
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 4
SA - Sud America 4
OC - Oceania 1
Totale 5.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.364
IE - Irlanda 1.096
DE - Germania 447
SE - Svezia 376
UA - Ucraina 371
IT - Italia 323
CN - Cina 231
HK - Hong Kong 212
SG - Singapore 159
FR - Francia 72
GB - Regno Unito 52
FI - Finlandia 31
VN - Vietnam 18
IN - India 17
BE - Belgio 16
NL - Olanda 12
EU - Europa 11
CZ - Repubblica Ceca 10
PK - Pakistan 10
RU - Federazione Russa 10
CA - Canada 8
IR - Iran 8
TR - Turchia 5
PH - Filippine 4
CH - Svizzera 3
RO - Romania 3
CL - Cile 2
GR - Grecia 2
KG - Kirghizistan 2
MX - Messico 2
RS - Serbia 2
ZA - Sudafrica 2
AT - Austria 1
BD - Bangladesh 1
BO - Bolivia 1
BR - Brasile 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
ES - Italia 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PR - Porto Rico 1
PT - Portogallo 1
Totale 5.899
Salva come PNG Salva come JPEG
Città #
Dublin 1.089
Jacksonville 748
Dearborn 365
Hong Kong 212
Lawrence 142
Princeton 142
Wilmington 141
San Mateo 121
Beijing 108
Singapore 105
Ann Arbor 93
Chandler 71
Ashburn 66
Piemonte 39
Houston 28
Seattle 28
Helsinki 27
Novara 23
Nanjing 21
Torino 21
Dong Ket 18
Hefei 18
Norwalk 17
Turin 17
Brussels 16
Woodbridge 16
Milan 15
Andover 14
Kunming 14
Munich 12
Nanchang 12
Boardman 10
Brno 10
Quetta 10
Saint Louis 10
Bremen 9
Alba 8
Jinan 8
Paris 8
Grafing 7
Guangzhou 7
Alessandria 6
Berlin 6
Rome 6
Brescia 5
Fairfield 5
Los Angeles 5
Naples 5
New York 5
Palermo 5
Philadelphia 5
Augusta 4
Fuzhou 4
Gunzenhausen 4
Kocaeli 4
Leawood 4
London 4
San Diego 4
Strasbourg 4
Toronto 4
West Jordan 4
Ardabil 3
Bibbiano 3
Bologna 3
Cambridge 3
Changsha 3
Chatsworth 3
Chengdu 3
Messina 3
Ottawa 3
Ovada 3
Pioltello 3
Redwood City 3
Santa Clara 3
Shanghai 3
Shenyang 3
Yekaterinburg 3
Appiano Gentile 2
Athens 2
Bagnoli del Trigno 2
Baotou 2
Bishkek 2
Bucharest 2
Bulandshahr 2
Busalla 2
Caloocan City 2
Dallas 2
Düsseldorf 2
Frankfurt am Main 2
Giugliano In Campania 2
Glendale 2
Hebei 2
Kish 2
Las Vegas 2
Leiden 2
Lognes 2
Massa 2
Monmouth Junction 2
Monterrey 2
Mülheim 2
Totale 4.033
Salva come PNG Salva come JPEG
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 143
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 135
Role of beta-blockers in patients with COPD: current perspective. 110
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 103
DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases 96
Change over time of COVID-19 hospital presentation in Northern Italy 94
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 94
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 74
Identification of Key Phospholipids That Bind and Activate Atypical PKCs 72
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside ICU 64
Ambroxol in the 21st century: pharmacological and clinical update 60
EXHALED NITRIC OXIDE AS A MARKER OF LUNG INVOLVEMENT IN CROHN'S DISEASE 57
DOXAZOSIN IN THE TREATMENT OF HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 56
ACUTE VENTILATORY AND GAS-EXCHANGE EFFECTS OF A NEW BETA-2 AGONIST, BROXATEROL, IN ASTHMATICS 52
Analysis of mitochondrial DNA alteration in new phenotype ACOS 51
Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome? 51
Biological investigations | [Indagini biologiche] 50
Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease 49
Age-Related Increase of Airway Neutrophils in Older Healthy Nonsmoking Subjects 49
[Alpha 1-antitrypsin deficiency: the Brescia clinical study]. FT Il deficit di alpha 1-antitripsina: lo studio clinico di Brescia. 49
Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma. 49
Acute respiratory distress following intravenous injection of trichloroethylene 49
Biological investigations | [Indagini biologiche] 49
Aging and induced-sputum cells 48
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 48
Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD 48
THE POTENTIAL THERAPEUTIC ROLE OF POTASSIUM CHANNEL MODULATORS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE 47
Micellar electrokinetic chromatography determination of desmosine in urine from patients with chronic lung disease. 47
Biological investigation in respiratory medicine [Indagini biologiche in pneumologia] 47
Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 46
[Infective pneumopathies in old age]. FT Pneumopatie infettive in eta geriatrica. 45
PNEUMOLOGY 45
Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients. 45
Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: A model to study tuberculosis immunity 45
ERYTHROCYTE POTASSIUM CONTENT AND ACID-BASE-EQUILIBRIUM IN PATIENTS WITH HEPATIC CIRRHOSIS - EFFECT OF ORAL POTASSIUM-CHLORIDE ADMINISTRATION 45
Determinants of smoking status in a sample of outpatients afferent to a tertiary referral hospital 45
[General practitioner and respiratory medicine specialist. A survey on the management of the asthmatic patient]. FT Indagine conoscitiva sul rapporto tra medico di medicina generale e specialista in medicina respiratoria nella gestione clinica del paziente asmatico. 44
Biologic and pharmacologic therapies in clinical development for the inflammatory response in COPD 44
[Pharmacologic control of breathing]. FT Controllo farmacologico della ventilazione. 44
Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement 44
Non-Invasive Biomarkers of Lung Inflammation in Smoking Subjects 44
Interrelationship among Obstructive Sleep Apnea,Renal Function and Survival: A Cohort Study 44
ANDOLAST ACTS AT DIFFERENT CELLULAR LEVELS TO INHIBIT IMMUNOGLOBULIN E SYNTHESIS 43
A randomized trial of cefepime and ceftazidime for the treatment of community-acquired pneumonia 43
[Tracheal stenosis due to metastatic adenopathic compression from breast carcinoma]. FT Stenosi tracheale per compressione adenopatica metastatica da carcinoma della mammella. 42
Identification of IL-17F/frequent exacerbator endotype in asthma 42
The Combined Impact of Exhaled Nitric Oxide and Sputum Eosinophils Monitoring in Asthma Treatment: A Prospective Cohort Study 42
Antihypertensive efficacy and tolerability of captopril in the elderly: comparison with hydrochlorothiazide and placebo in a multicentre, double-blind study. 42
Effect of two beta(2)-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis 42
[Changes in the heart rhythm and slow-release beta-2 agonist therapy (peroral) in asthmatic patients. A Holter study]. Alterazioni del ritmo cardiaco e terapia beta-2-agonista a lento rilascio (per via orale) in pazienti asmatici. Studio Holter. 41
Long term adjustment of stable asthma treatment with fractional exhaled nitric oxide and sputum eosinophils 41
Psoriasis and risk of myocardial infarction 41
[Rhinitis and asthma]. FT Rinite e asma. 41
Vilanterol trifenatate for the treatment of COPD. 41
Association of FEF25-75% Impairment with Bronchial Hyperresponsiveness and Airway Inflammation in Subjects with Asthma-Like Symptoms 41
SEVERE INTRAVASCULAR HAEMOLYSIS AS DELAYED MANIFESTATION OF PERIVALVULAR LEAK IN PATIENTS WITH MITRAL VALVE REPLACEMENT: A REPORT OF TWO CASES 41
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD. 41
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis 40
Dupilumab for the treatment of asthma 40
DAYTIME AND NIGHTTIME POWER SPECTRAL-ANALYSIS OF HEART-RATE IN HYPERTENSIVE PATIENTS WITH AND WITHOUT LEFT-VENTRICULAR HYPERTROPHY 40
Increased airway inflammation in patients with psoriasis 40
Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects 40
Airway hyperresponsiveness in a large group of subjects with alpha(1)-antitrypsin deficiency: a cross-sectional controlled study 40
Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment 40
[Respiratory effects of antihypertensive agents acting on alpha adrenergic receptors]. Effetti respiratori dei farmaci antiipertensivi che agiscono sui recettori alfa adrenergici. 40
Effects of 'slow-release' salbutamol on respiratory function in asthmatic patients 40
Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. 39
Uremic lung. 39
C-REACTIVE PROTEIN AND MARKERS FOR THROMBOPHILIA IN PATIENTS WITH CHRONIC PLAQUE PSORIASIS 39
EXHALED NITRIC OXIDE IS RELATED TO BRONCHIAL EOSINOPHILIA AND AIRWAY HYPERRESPONSIVENESS TO BRADYKININ IN ALLERGEN-INDUCED ASTHMA EXACERBATION 39
Ineffectiveness of intravenous beta(2)-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction 39
Diagnosis of Chronic Obstructive Pulmonary Disease, simpler is better Complexity and simplicity 39
Exhaled breath temperature measurement: Influence of circadian rhythm 39
RENAL NORADRENERGIC AND DOPAMINERGIC ACTIVITY IN PATIENTS WITH BORDERLINE ESSENTIAL-HYPERTENSION 39
Efficacy of Andolast in Mild to Moderate Asthma: A Randomized, Controlled, Double-Blind Multicentre Study (The ANDAST Trial) 39
Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects 39
Reference values for exhaled nitric oxide (reveno) study 39
Usefulness of Exhaled Nitric Oxide and Sputum Eosinophils in the Long-term Control of Eosinophilic Asthma 38
Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease 38
Ceftizoxlme for the treatment of exacerbations of chronic obstructive pulmonary diseases 38
Folic acid in general medicine and dermatology 38
Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping 38
Glucocorticoid-induced osteoporosis in asthma and respiratory diseases 38
EFFICACY AND SAFETY OF MOGUISTEINE IN COMPARISON WITH DEXTROMETHORPHAN IN PATIENTS WITH PERSISTENT COUGH 38
Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma 38
Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD - role of umeclidinium/vilanterol 38
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease 38
Biological investigations in pulmonology [Indagini biologiche in pneumologia] 38
Values in Elderly People for Exhaled Nitric Oxide Study 38
Nasal IL-17F is related to bronchial IL-17F/neutrophilia and exacerbations in stable atopic severe asthma 37
High serum levels of tumour necrosis factor-alpha and interleukin-8 in severe asthma: markers of systemic inflammation? 37
Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease. 37
CONTROLLED-RELEASE ORAL SALBUTAMOL AND CARDIAC-ARRHYTHMIAS IN ASTHMATIC-PATIENTS 37
Cardiac arrhythmia monitoring during bronchial provocation test with methacholine 37
[Severe alpha 1-antitrypsin deficiency: cross sectional clinical study]. FT Grave deficit di alpha 1-antitripsina: studio clinico trasversale. 37
Endothelial dysfunction assessment by noninvasive peripheral arterial tonometry in patients with chronic obstructive pulmonary disease compared with healthy subjects 37
Potential role of hematological parameters in patients with chronic obstructive pulmonary disease: current point of view 37
Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial) 37
Potential role of diacylglycerol kinases in immune-mediated diseases 37
Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension 36
Totale 4.796
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.173
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.136 0 0 0 0 231 209 268 88 135 72 129 4
2020/2021941 130 0 127 4 159 26 146 7 151 20 143 28
2021/2022979 39 13 142 93 63 21 53 27 98 19 124 287
2022/20231.707 156 89 61 20 31 77 61 70 1.049 13 60 20
2023/2024707 43 47 32 25 130 12 81 20 13 7 150 147
2024/2025138 23 15 42 28 30 0 0 0 0 0 0 0
Totale 6.117